ARGA Investment Management LP Takes Position in Acadia Healthcare Company, Inc. $ACHC

ARGA Investment Management LP purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the third quarter, HoldingsChannel reports. The firm purchased 44,031 shares of the company’s stock, valued at approximately $1,090,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of Acadia Healthcare during the first quarter valued at approximately $1,600,000. Goldman Sachs Group Inc. boosted its stake in Acadia Healthcare by 21.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after purchasing an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after purchasing an additional 27,207 shares in the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Acadia Healthcare by 2.6% in the second quarter. Public Employees Retirement System of Ohio now owns 30,468 shares of the company’s stock worth $691,000 after purchasing an additional 760 shares during the last quarter. Finally, Signaturefd LLC lifted its holdings in shares of Acadia Healthcare by 1,451.7% during the second quarter. Signaturefd LLC now owns 5,043 shares of the company’s stock valued at $114,000 after purchasing an additional 4,718 shares in the last quarter.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Jefferies Financial Group downgraded Acadia Healthcare to a “hold” rating in a report on Thursday. Raymond James Financial set a $17.00 price target on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Royal Bank Of Canada lowered their price objective on shares of Acadia Healthcare from $19.00 to $17.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 14th. Barclays cut their target price on shares of Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating for the company in a research report on Thursday, December 4th. Finally, KeyCorp lowered their price target on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, December 3rd. Six research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Hold” and an average price target of $18.62.

Acadia Healthcare Stock Up 0.5%

ACHC opened at $15.23 on Friday. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $45.61. The firm’s 50 day simple moving average is $14.47 and its two-hundred day simple moving average is $19.65. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $1.41 billion, a PE ratio of 13.02, a PEG ratio of 4.31 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.71 by $0.01. The firm had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.Acadia Healthcare’s revenue was up 4.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.